• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Sci Rep . Exploring the effects of N234 and N343 linked glycans to SARS CoV 2 spike protein pocket accessibility using Gaussian accelerated molecul

tetano

Editor, Senior Moderator
Sci Rep


. 2025 Feb 27;15(1):7052.
doi: 10.1038/s41598-025-85153-5. Exploring the effects of N234 and N343 linked glycans to SARS CoV 2 spike protein pocket accessibility using Gaussian accelerated molecular dynamics simulations

Ronny L Cheng[SUP] 1 [/SUP], James Peter L Lim[SUP] 1 [/SUP], Myrnel A Fortuna[SUP] 1 [/SUP], Donnifer V Reyes Jr[SUP] 1 [/SUP], Earl Adrian D R Hans[SUP] 1 [/SUP], Ricky B Nellas[SUP] 2 [/SUP]



Affiliations
Abstract

The N234 and N343-linked glycans of the SARS-CoV 2 spike protein are known to stabilize the up-conformation of its receptor-binding domains (RBDs), enabling human angiotensin enzyme 2 (hACE2) receptor binding. However, the effect of spike-hACE2 binding on these important glycans remains poorly understood, and these changes could have implications in the development of drugs that inhibit viral entry. In this study, Gaussian accelerated molecular dynamics (GaMD) simulations of the hACE2-free and hACE2-bound spike protein are performed. Biophysical analyses were focused on the accessibility of three previously suggested druggable pockets underneath the three RBD subunits. A shielding effect by N234-linked glycans on the components of their adjacent pockets was observed. Although deshielding of central scaffold residues was observed in the hACE2-bound state, pocket A's accessibility was reduced due to an increase in NTD[SUB]B[/SUB]-RBD[SUB]B[/SUB] contacts, restricting entry into the pocket. For pocket B, changes in N234[SUB]C[/SUB] and N343[SUB]C[/SUB] expose the central scaffold residues in the bound state, increasing accessibility. In Pocket C, increased shielding due to N234[SUB]A[/SUB] was found in the bound state, reducing accessibility. Despite these changes, the pockets remain accessible to ligands in both states and are still valid targets for drug development studies.

Keywords: Biophysical analysis; COVID-19; Gaussian accelerated molecular dynamics; Glycosylation; SARS-CoV-2 spike protein.

 
Back
Top Bottom